REViVALS-1A: Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis

Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith

http://clinicaltrials.gov/ct2/show/NCT04632225

Feb 21, 2021